Provocation Tests in Drug Hypersensitivity

Immunology and Allergy Clinics of North America

Volumn 29, Issue 3, 2009, Pages 567-584

  Aberer, Werner ^a   Kränke, Birger ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Challenge test; Diagnosis; Drug allergy; Drug hypersensitivity; Provocation test

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CEFACLOR; CEFIXIME; CEFTRIAXONE; CIPROFLOXACIN; CONTRAST MEDIUM; HEPARIN DERIVATIVE; LIDOCAINE; MELOXICAM; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PREDNISOLONE; TETRAZEPAM; VACCINE;

DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG HYPERSENSITIVITY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; GOLD STANDARD; HIGH RISK POPULATION; HUMAN; PRIORITY JOURNAL; PROVOCATION TEST; RELIABILITY; REVIEW; RISK BENEFIT ANALYSIS; SKIN TEST; TREATMENT CONTRAINDICATION; TREATMENT INDICATION;

DESENSITIZATION, IMMUNOLOGIC; DIAGNOSTIC ERRORS; DRUG HYPERSENSITIVITY; FEASIBILITY STUDIES; HUMANS; IMMUNOLOGIC TESTS; IMMUNOSUPPRESSION; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; STATISTICS AS TOPIC;

EID: 67649206470     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.iac.2009.04.008     Document Type: Review

References (50)

1. Aberer W., Bircher A., Romano A., et al. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy 58 (2003) 854-863
2. Bousquet P.-J., Gaeta F., Bousquet-Rouanet L., et al. Provocation tests in diagnosing drug hypersensitivity. Curr Pharm Des 14 (2008) 2792-2802
3. Gomes E., Cardoso M.F., Praca F., et al. Self-reported drug allergy in a general adult Portuguese population. Clin Exp Allergy 34 (2004) 1597-1601
4. Solensky R. Drug hypersensitivity. Med Clin North Am 90 (2006) 233-260
5. Lazarou J., Pomeranz B.H., and Corey P.N. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 279 (1998) 1200-1205
6. Demoly P., Pichler W., Pirmohamed M., et al. Important questions in allergy: 1-drug allergy/hypersensitivity. Allergy 63 (2008) 616-619
7. Weiss M., and Adkinson Jr. N. Diagnostic testing for drug hypersensitivity. Immunol Allergy Clin North Am 18 (1998) 731-744
8. Bach S., and Bircher A.J. Drug hypersensitivity reactions: from clinical manifestations to an allergologic diagnosis. Allerg Immunol (Paris) 37 (2005) 213-218
9. Romano A., Quarantine D., Di Fonso M., et al. A diagnostic protocol for evaluating nonimmediate reactions to aminopenicillins. J Allergy Clin Immunol 103 (1999) 1186-1190
10. Stark B.J., Earl H.S., Gross G.N., et al. Acute and chronic desensitization of penicillin-allergic patients using oral penicillin. J Allergy Clin Immunol 79 (1987) 523-532
11. Demoly P., Kropf R., Bircher A., et al. Drug hypersensitivity: questionnaire. Allergy 54 (1999) 999-1003
12. Aberer W., and Kränke B. Clinical manifestations and mechanisms of skin reactions after systemic drug administration. Drug Discov Today Dis Mech 5 (2008) e237-e247 [Epub ahead of print]
13. Brockow K., Romano A., Blanca M., et al. General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy 57 (2002) 45-51
14. Aberer W., Zidarn M., and Kränke B. IgE antibodies to penicillin are indicative for but not conclusive proof of penicillin allergy. Br J Dermatol 154 (2006) 1209-1210
15. Barbaud A., Goncalo M., Bruynzeel D., et al. Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions. Contact Derm 45 (2001) 321-328
16. Pichler W.J., and Tilch J. The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy 59 (2004) 809-820
17. DeWeck A.L., Sanz M.L., Gamboa P.M., et al. Diagnostic tests based on human basophils: more potentials and perspectives than pitfalls. Int Arch Allergy Immunol 146 (2008) 177-189
18. Baluga J.C., Casmayou R., Carozzi E., et al. Allergy to local anaesthetics in dentistry. Myth or reality?. Allergol Immunopathol (Madrid) 30 (2002) 14-19
19. Mahboob A., Haroon T.S., Iqbal Z., et al. Fixed drug eruption and intradermal provocation tests. J Coll Physicians Surg Pak 18 (2008) 736-739
20. Guglielmi L., Guglielmi P., and Demoly P. Drug hypersensitivity: epidemiology and risk factors. Curr Pharm Des 12 (2006) 3309-3312
21. Davis C., and Shearer W.T. Diagnosis and management of HIV drug hypersensitivity. J Allergy Clin Immunol 121 (2008) 826-832
22. Bernstein M.L., McCusker M.M., and Grant-Kels J.M. Cutaneous manifestations of cystic fibrosis. Pediatr Dermatol 25 (2008) 150-157
23. Feldweg A.M., Lee C.M., Matulonis U.A., et al. Rapid desensitization for hypersensitivity reactions to paclitaxel and docetaxel: a new standard protocol used in 77 successful treatments. Gynecol Oncol 96 (2005) 824-829
24. Solensky R., Earl H.S., and Gruchalla R.S. Lack of penicillin resensitization in patients with a history of penicillin allergy after receiving repeated penicillin courses. Arch Intern Med 162 (2002) 822-826
25. Lieberman P., Kemp S., Oppenheimer J.J., et al. The diagnosis and management of anaphylaxis: an update practice parameter. J Allergy Clin Immunol 115 Suppl (2005) S483-S523
26. Sampson H.A., Munoz-Furlong A., Campbell R.L., et al. Second symposium on the definition and management of anaphylaxis: summary report. J Allergy Clin Immunol 117 (2006) 391-397
27. Reidenberg M.M., and Lowenthal D.T. Adverse nondrug reactions. N Engl J Med 279 (1968) 678-679
28. Bernstein L., Gruchalla R.S., Lee R., et al. Executive summary of disease management of drug hypersensitivity: a practice parameter. Ann Allergy Asthma Immunol 83 (1999) 665-700
29. Torres M.J., Blanca M., Fernandez J., et al. Diagnosis of immediate allergic reactions to beta-lactam antibiotics. Allergy 58 (2003) 961-972
30. Romano A., Blanca M., Torres M.J., et al. Diagnosis of nonimmediate reactions to beta-lactam antibiotics. Allergy 59 (2004) 1153-1160
31. Grims R.H., Kränke B., and Aberer W. Pitfalls in drug allergy skin testing: false-positive reactions due to (hidden) additives. Contact Derm 54 (2006) 290-294
32. Messaad D., Sahla H., Benahmed S., et al. Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction. Ann Intern Med 140 (2004) 1001-1006
33. Greenberger P.A. Drug allergy. J Allergy Clin Immunol 117 Suppl (2006) S464-S470
34. Nizankowska-Mogilnicka E., Bochenek G., Mastalerz L., et al. EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity. Allergy 62 (2007) 1111-1118
35. Przybilla B., Aberer W., Bircher A.J., et al. Allergological approach to drug hypersensitivity reactions. J Dtsch Dermatol Ges 6 (2008) 240-243
36. Wöhrl S. Clinical work-up of adverse drug reactions. Expert Rev Dermatol 2 (2007) 217-231
37. Komericki P., Arbab E., Grims R., et al. Tryptase as severity marker in drug provocation tests. Int Arch Allergy Immunol 140 (2006) 164-169
38. Moore N., Biour M., Paux G., et al. Adverse drug reaction monitoring: doing it the French way. Lancet 2 8463 (1985) 1056-1058
39. Benahmed S., Picot M.C., Dumas F., et al. Accuracy of a pharmacovigilance algorithm in diagnosing drug hypersensitivity reactions. Arch Intern Med 165 (2005) 1500-1505
40. Girard M. Conclusiveness of rechallenge in the interpretation of adverse drug reactions. Br J Clin Pharmacol 23 (1987) 73-79
41. Yocum M.W., Heller A.M., and Abels R.I. Efficacy of intravenous pretesting and antihistamine prophylaxis in radiocontrast media-sensitive patients. J Allergy Clin Immunol 62 (1978) 309-313
42. Mendelson L.M., Ressler C., Rosen J.P., et al. Routine elective penicillin allergy skin testing in children and adolescents: study of sensitization. J Allergy Clin Immunol 73 (1984) 76-81
43. Pichichero M.E., and Pichichero D.M. Diagnosis of penicillin, amoxicillin, and cephalosporin allergy: reliability of examination assessed by skin testing and oral challenge. J Pediatr 132 (1998) 137-143
44. Wöhrl S., Vigl K., and Stingl G. Patients with drug reactions-is it worth testing?. Allergy 61 (2006) 928-934
45. Venulet J. Role and place of causality assessment. Pharmacoepidemiol Drug Saf 1 (1992) 225-234
46. Grims R.H., Weger W., Reiter H., et al. Delayed-type hypersensitivity to low molecular weight heparins and heparinoids: cross-reactivity does not depend on molecular weight. Br J Dermatol 157 (2007) 514-517
47. Brockow K., Romano A., Aberer W., et al. Skin testing in patients with hypersensitivity reactions to iodinated contrast media-a European multicenter study. Allergy 64 (2009) 234-241
48. Adkinson Jr. N.F., Essayan D., Gruchalla R., et al. Task force report: future research needs for the prevention and management of immune-mediated drug hypersensitivity reactions. J Allergy Clin Immunol 109 Suppl (2002) S461-S478
49. Pirmohamed M. Genetic factors in the predisposition to drug-induced hypersensitivity reactions. AAPS J 8 (2006) e20-e26
50. Koh Y., Yap C.W., and Li S.C. A quantitative approach of using genetic algorithm in designing a probability scoring system of an adverse drug reaction assessment system. Int J Med Inf 77 (2008) 421-430